Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy
- 1 July 2006
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 65 (3) , 669-677
- https://doi.org/10.1016/j.ijrobp.2006.01.030
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Minimizing prostate brachytherapy-related morbidityUrology, 2003
- Permanent Interstitial Brachytherapy for the Management of Carcinoma of the Prostate GlandJournal of Urology, 2003
- Long‐term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinomaCancer, 2003
- The role of hormonal therapy in prostate brachytherapyBrachytherapy, 2003
- Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantationInternational Journal of Radiation Oncology*Biology*Physics, 2002
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Examining the Role of Neoadjuvant Androgen Deprivation in Patients Undergoing Prostate BrachytherapyJournal of Clinical Oncology, 2000
- Palladium-103 brachytherapy for prostate carcinomaPublished by Elsevier ,2000